Published in Gut on March 01, 1976
Diet and Crohn's disease: characteristics of the pre-illness diet. Br Med J (1979) 2.93
Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut (1984) 2.70
Prognosis in Crohn's disease--based on results from a regional patient group from the county of Copenhagen. Gut (1985) 2.56
Epidemiological aspects of Crohn's disease: a review of the literature. Gut (1984) 2.04
Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg (2000) 1.92
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut (2006) 1.87
The social toll of Crohn's disease. Br Med J (1978) 1.80
Systematic association mapping identifies NELL1 as a novel IBD disease gene. PLoS One (2007) 1.57
Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet (1999) 1.57
Crohn's disease of the distal ileum. Gut (1980) 1.55
Treatment of Crohn's disease with an unrefined-carbohydrate, fibre-rich diet. Br Med J (1979) 1.39
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion. Nature (2014) 1.35
Crohn's disease in the elderly. Gut (1985) 1.27
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut (2005) 1.26
Breakfast and Crohn's disease. Br Med J (1977) 1.22
Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p. Proc Natl Acad Sci U S A (2001) 1.17
Mortality and causes of death in Crohn's disease. Review of 50 years' experience in Leiden University Hospital. Gut (1990) 1.04
Crohn's disease: risk of recurrence and reoperation in a defined population. Gut (1989) 1.02
The long-term outcome of restorative operation in Crohn's disease: influence of location, prognostic factors and surgical guidelines. Ann Surg (1982) 0.97
Health related quality of life in inflammatory bowel disease: the impact of surgical therapy. World J Gastroenterol (2010) 0.86
A case-only study of gene-environment interaction between genetic susceptibility variants in NOD2 and cigarette smoking in Crohn's disease aetiology. BMC Med Genet (2012) 0.81
Factors in the management of Crohn's disease: a discussion paper. J R Soc Med (1981) 0.81
The quality of life in Crohn's disease. Gut (1987) 0.81
Coagulation parameters in inflammatory bowel disease. Int J Clin Exp Med (2014) 0.81
Crohn's disease in the elderly. Br Med J (Clin Res Ed) (1985) 0.80
Long term prognosis of Crohn's disease with onset in childhood and adolescence. Gut (1984) 0.78
Serum Cytokine Profiles in Children with Crohn's Disease. Mediators Inflamm (2016) 0.75
Prognosis of Crohn's disease. Br Med J (Clin Res Ed) (1981) 0.75
The impact of thiopurines on surgical outcomes in inflammatory bowel disease: do they make a difference? F1000Prime Rep (2013) 0.75
Nonspecific inflammatory bowel disease in two general hospitals. J R Soc Med (1978) 0.75
THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. Gut (1963) 6.34
An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area. Gut (1965) 5.25
Prognosis after resection of chronic regional ileitis. Gut (1967) 3.27
Changing patterns in epidemiology of Crohn's disease. Lancet (1974) 2.99
Crohn's disease in a defined population. An epidemiological study of incidence, prevalence, mortality, and secular trends in the city of Malmö, Sweden. Gastroenterology (1975) 2.94
Short-term course and prognosis of Crohn's disease. Gut (1974) 2.90
Crohn's disease and cancer. N Engl J Med (1973) 2.68
The early and late results of surgical treatment for Crohn's disease. Br J Surg (1971) 1.90
An epidemiological study of Crohn's disease. Scand J Gastroenterol (1970) 1.81
Crohn's disease and carcinoma of colon. Br Med J (1968) 1.77
Mortality in Crohn's disease. Lancet (1970) 1.71
Morbidity and mortality in regional enteritis. Report of 168 cases. Am J Dig Dis (1969) 1.33
Crohn's disease. A clinical study based on 186 patients. Scand J Gastroenterol (1971) 1.25
The liver in Crohn's disease. Q J Med (1971) 1.16
An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet (1977) 7.89
A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin). Gut (1973) 6.09
The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens. J Clin Pathol (1972) 6.07
Haematemesis and melaena, with special reference to factors influencing the outcome. Br Med J (1970) 4.31
Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet (1974) 4.06
Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut (1988) 3.66
Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk. Br Med J (1979) 3.56
Transit times of food in patients with diverticulosis or irritable colon syndrome and normal subjects. Br Med J (1967) 3.51
Prevalence of colonic diverticulosis in general population of Oxford area. Br Med J (1967) 3.44
Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. Gut (1980) 2.81
Gastric ulcer and gastritis. Gut (1971) 2.58
Gastric cancer simulating benign gastric ulcer. Br J Surg (1969) 2.27
Auto-immune reactions in ulcerative colitis. Gut (1966) 2.26
Further experience in the treatment of severe attacks of ulcerative colitis. Lancet (1978) 2.25
Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. Br Med J (1974) 2.24
Method of preparing isolated colonic epithelial cells (colonocytes) for metabolic studies. Gut (1979) 2.08
Jejunal mucosal recovery in coeliac disease in relation to the degree of adherence to a gluten-free diet. Q J Med (1974) 1.95
Ulcerative colitis and pregnancy. Gut (1980) 1.90
The histological classification of duodenitis in fibreoptic biopsy specimens. Digestion (1975) 1.89
Crohn's disease and carcinoma of colon. Br Med J (1968) 1.77
Abnormalities in the apparently normal bowel mucosa in Crohn's disease. Lancet (1976) 1.77
Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis. Gut (1982) 1.60
Gastroscopy with biopsy and cytological sampling under direct vision. Br Med J (1968) 1.53
Disaccharidase activity and jejunal morphology in coeliac disease. Q J Med (1972) 1.48
The effect of topical N-acetyl-5-aminosalicylic acid in ulcerative colitis. Scand J Gastroenterol (1980) 1.46
Hypolactasia and the irritable colon syndrome. Scand J Gastroenterol (1972) 1.42
Comparison of disodium cromoglycate and sulphasalazine as maintenance therapy for ulcerative colitis. Lancet (1979) 1.40
The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. Br J Clin Pharmacol (1982) 1.40
Immunosuppression in the treatment of inflammatory bowel disease. I. Changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine. Clin Exp Immunol (1974) 1.39
Circulating and tissue eosinophils in ulcerative colitis. Am J Dig Dis (1966) 1.32
Lack of harmful effect of oats on small-intestinal mucosa in coeliac disease. Br Med J (1974) 1.31
Stimulation of lymphocytes from patients with coeliac disease by a subfraction of gluten. Lancet (1976) 1.31
Propulsion and retropulsion of normal colonic contents. Am J Dig Dis (1971) 1.30
The timing of histological damage following a single challenge with gluten in treated coeliac disease. Q J Med (1981) 1.29
Azathioprine in ulcerative colitis: an interim report on a controlled therapeutic trial. Br Med J (1972) 1.28
The liver in ulcerative colitis. Q J Med (1971) 1.27
Glucosamine synthetase activity of the colonic mucosa in ulcerative colitis and Crohn's disease. Gut (1977) 1.26
HLA-DRB1*03, but not the TNFA -308 promoter gene polymorphism, confers protection against fistulising Crohn's disease. Immunogenetics (1998) 1.25
Gastritis duodenitis, and circulating levels of gastrin in duodenal ulcer before and after vagotomy. Gut (1976) 1.25
Cerebral venous thrombosis as a complication of ulcerative colitis. Am J Dig Dis (1967) 1.25
Comparison of various treatments for irritable bowel syndrome. Br Med J (1980) 1.20
The role of various cereals in coeliac disease. Q J Med (1978) 1.19
Are activity indices helpful in assessing active intestinal inflammation in Crohn's disease? Gut (1989) 1.17
The liver in Crohn's disease. Q J Med (1971) 1.16
Circulating antibodies to cow's milk proteins in ulcerative colitis. Gut (1972) 1.16
Identifying toxic fractions of wheat gluten and their effect on the jejunal mucosa in coeliac disease. Gut (1974) 1.13
Proctocolectomy for ulcerative colitis. World J Surg (1980) 1.12
Campylobacter colitis. J Clin Pathol (1979) 1.12
Intensive intravenous regimen for membranous colitis. Br Med J (1976) 1.11
Tissue eosinophils in ulcerative colitis. Scand J Gastroenterol (1979) 1.10
The management of ulcerative colitis. Br J Clin Pract (1974) 1.07
Wheat grains: a substrate for the determination of gluten antibodies in serum of gluten-sensitive patients. J Immunol Methods (1977) 1.06
Split ileostomy and ileocolostomy for Crohn's disease of the colon and ulcerative colitis: a 20 year survey. Gut (1983) 1.06
Circulating levels of sulphasalazine and its metabolites and their relation to the clinical efficacy of the drug in ulcerative colitis. Gut (1980) 1.06
Luminal ions and short chain fatty acids as markers of functional activity of the mucosa in ulcerative colitis. J Clin Pathol (1982) 1.05
Water and electrolyte balance in subjects with a permanent ileostomy. Gut (1983) 1.05
Placental and mammary transfer of sulphasalazine. Br Med J (1979) 1.04
The effects of prednisolone in leucocyte function in man. A double blind controlled study. Clin Exp Immunol (1977) 1.04
Movements of the large intestine. Physiol Rev (1966) 1.04
The health of subjects living with a permanent ileostomy. Q J Med (1982) 1.04
Skin test for coeliac disease using a subfraction of gluten. Lancet (1977) 1.04
Crohn's disease: risk of recurrence and reoperation in a defined population. Gut (1989) 1.02
Segmentation and the localization of intraluminal pressure in the human colon, with special reference to the pathogenesis of colonic diverticula. Gastroenterology (1968) 1.01
Multidisciplinary approach to understand the pathogenesis of gastric cancer. World J Gastroenterol (2005) 1.01
Breakfast and Crohn's disease--I. Br Med J (1978) 1.00
Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis. Clin Exp Immunol (1976) 0.96
Environmental risk factors in inflammatory bowel disease. Hepatogastroenterology (1996) 0.95
The effect of the acetylator phenotype on the metabolism of sulphasalazine in man. J Med Genet (1983) 0.94
Circulating immune complexes in ulcerative colitis and Crohn's disease. Gut (1972) 0.94
Pericarditis associated with ulcerative colitis and Crohn's disease. Am J Dig Dis (1976) 0.92
Medical management of ulcerative colitis. Br Med J (1968) 0.91
Haustral movement in the human colon. Gut (1969) 0.90
Reaginic hypersensitivity in ulcerative colitis. Gut (1972) 0.90
Blood Groups and Secretor Status in Ulcerative Colitis. Br Med J (1961) 0.89
The thyroid in ulverative colitis and Crohn's disease. II. Thyroid enlargement and hyperthyroidism in ulcerative colitis. Acta Med Scand (1975) 0.87
Disodium azodisalicylate in ulcerative colitis. Lancet (1981) 0.87
Transient paraproteinaemia in a patient with coeliac disease. Gut (1976) 0.86
Seropositivity in Dutch Crohn's disease patients against primed nude mouse lymph nodes, and the difference with lymphocytotoxic antibodies. Gut (1986) 0.84
Human colonic motility. A comparative study of normal subjects, patients with ulcerative colitis, and patients with the irritable colon syndrome. Gastroenterology (1968) 0.83
Propulsion and retropulsion in the human colon demonstrated by time-lapse cinefluorography. Gut (1968) 0.83
Hookworm infection in Great Britain: experimental observations. Br Med J (1965) 0.83
Prevalence of macrocreatinkinase type 1 in patients with inflammatory bowel disease. Dig Dis Sci (2007) 0.82
A comparative study of extraction apparatus in HPLC analysis of ochratoxin A in muscle. Anal Bioanal Chem (2005) 0.82
Observations on experimentally induced colonic pain. Gut (1972) 0.82
Gut hormone responses in subjects with a permanent ileostomy. Digestion (1982) 0.82
Medical management of ulcerative colitis and indications for colectomy. World J Surg (1988) 0.81
Small intestinal mucosal abnormalities and disaccharidase activity in pernicious anaemia. Br J Haematol (1972) 0.81
Morphology and disaccharidase levels of jejunal biopsy specimens from healt by british subjects. Digestion (1973) 0.81
Levels of ochratoxin A in serum from urban and rural Portuguese populations and estimation of exposure degree. Food Chem Toxicol (2007) 0.81
Regional enteritis and glucose-6-phosphate dehydrogenase deficiency. N Engl J Med (1969) 0.81
Urinary stones in subjects with a permanent ileostomy. Br J Surg (1982) 0.80
Hypolactasia and the irritable colon syndrome. Gut (1969) 0.79
Ulcerative colitis beginning in childhood. N Engl J Med (1971) 0.79
Probiotics: Isolated bacteria strain or mixtures of different strains? Two different approaches in the use of probiotics as therapeutics. Drugs Today (Barc) (2003) 0.79
Proceedings: The histological state of the gastric and duodenal mucosa in healthy volunteers. Gut (1975) 0.79
Ochratoxin A in nephropathic patients from two cities of central zone in Portugal. J Pharm Biomed Anal (2007) 0.78
A therapeutic trial of anti-lymphocytic globulin in acute ulcerative colitis. Digestion (1980) 0.78